@ARTICLE{
author={Cassidy Jonathan,Douillard Y,Twelves C,McKendrick JJ,Scheithauer W,Bustova I,Johnston PG,Lesniewski-Kmak L,Jelic Svetislav B,Fountzilas George,Coxon F,Diaz-Rubio E,Maughan TS,Malzyner A,Bertetto O,Beham A,Figer A,Dufour P,Patel KK,Cowell},
year={2006},
title={Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial},
journal={BRITISH JOURNAL OF CANCER},
volume={94},
number={8},
pages={1122-1129},
document_type={Article},
}